Nashville, United States
Ombre is a promising startup that has positioned itself at the nexus of science and self-care, harnessing the power of both to offer a uniquely personalized consumer experience. Founded in 2016, the company specializes in transforming health and wellness through its innovative at-home tests. These tests provide insights into an individual's microbiome and leverage DNA analysis to recommend personalized lifestyle and diet adjustments, along with strain-specific probiotics.
Operating within the Health Care and Health and Wellness industries, Ombre is headquartered in the United States. The company's notable last round of funding was a $4.00M Seed Round investment on February 15, 2022, led by Relevance Ventures. This strategic backing highlights investor confidence in Ombre's vision and potential for growth, as it continues to innovate at the intersection of scientific discovery and personalized healthcare. Such expertise not only advances healthcare insights but also enhances daily well-being on an individual level.
